Skip Navigation


NDT Advance Access originally published online on October 11, 2006
Nephrology Dialysis Transplantation 2007 22(2):584-591; doi:10.1093/ndt/gfl583
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/2/584    most recent
gfl583v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schwarz, A.
Right arrow Articles by Haller, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwarz, A.
Right arrow Articles by Haller, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Decreased renal transplant function after parathyroidectomy

Anke Schwarz, Gunnar Rustien, Saskia Merkel, Joerg Radermacher and Hermann Haller

Department of Nephrology, Hannover Medical School, Hannover, Germany

Correspondence and offprint requests to: Prof. Dr Anke Schwarz, Department of Nephrology, Hannover Medical School, Carl Neuberg Strasse 1, D-30625 Hannover, Germany. Email: schwarz.anke{at}mh-hannover.de



  Abstract

Background. Persistent secondary hyperparathyroidism after renal transplantation may require parathyroidectomy (PTX). Clinical experience suggests that these patients commonly develop decreased renal function thereafter.

Methods. To test this notion, we evaluated 76 transplant patients who underwent pararhyroidectomy between 1997 and 2003.

Results. In half the patients (47%), creatinine clearance decreased >20% (before vs after PTX, 57 ± 21 vs 38 ± 17 ml/min, P = 0.001). The patients with decreased creatinine clearance had higher parathyroid hormone (PTH) concentrations before and lower values after PTX compared with those who did not (594 ± 392 vs 447 ± 234 pg/ml before PTX, P = 0.03; 35 vs 123 pg/ml thereafter, P = 0.002). They also had lower serum calcium concentrations after PTX (2.0 vs 2.2 mmol/l, P = 0.005) and they required more calcium and vitamin D analogues. These patients also more commonly underwent total PTX with autotransplantation, compared with subtotal (75 vs 50%, P = 0.03). However, in multivariate analysis, only the delta PTH decline (%) after PTX was a significant predictor of deteriorating renal function (P = 0.005) and was correlated with the creatinine clearance decrease (R = 0.369, P = 0.001). Prospectively measured inulin and para-amino-hippuric acid (PAH) clearance decreased significantly after PTX in a subgroup of 19 patients (inulin before vs after PTX 67 vs 55 ml/min/1.73 m2, P = 0.001; PAH 360 vs 289 ml/min/1.73 m2, P = 0.001). Transplant biopsies revealed calcification in 70% of biopsied cases.

Conclusion. Since PTH has a known positive regulatory effect on renal perfusion and glomerular filtration rate, we conclude that relative hypoparathyroidism after PTX is the main mechanism contributing to decreased renal function in these patients. There was no difference in 10-year-graft survival between the deteriorating and the non-deteriorating group.

Keywords: hypercalcaemia; hyperparathyroidism; parathyroidectomy; parathyroid hormone; renal transplantation

The authors wish it to be known that, in their opinion, the first two authors contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
U. Kunzendorf, B. K. Kramer, W. Arns, J. Braun, J. Grossmann, F. Pietruck, H. Schmidt-Gayk, A. Schwarz, E. Ziegler, H. Sperschneider, et al.
Bone disease after renal transplantation
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 450 - 458.
[Full Text] [PDF]


Home page
NDT PlusHome page
M. Chonchol and R. P. Wuthrich
Potential Future Uses of Calcimimetics in Patients with Chronic Kidney Disease
NDT Plus, January 1, 2008; 1(suppl_1): i36 - i41.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. E. Kruse, U. Eisenberger, F. J. Frey, and M. G. Mohaupt
Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism
Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2362 - 2365.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.